Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials.
Monika GräserSimone SchradingOleg GluzKevin StrobelChristopher HerzogLale UmutluAlex FrydrychowiczDorothea Rjosk-DendorferRachel WürstleinRalph CulemannChristine EulenburgJascha AdamsHenrik NitzscheAnna PrangeSherko KümmelEva-Maria GrischkeHelmut ForstbauerMichael BraunJochem PotenbergRaquel von SchumannBahriye AktasCornelia Kolberg-LiedtkeNadia HarbeckChristiane K KuhlUlrike NitzPublished in: Breast cancer research : BCR (2021)
Clinicaltrials.gov , NCT01815242 (registered on March 21, 2013), NCT01817452 (registered on March 25, 2013), and NCT01779206 (registered on January 30, 2013).